CLDND1 Polyclonal Antibody

SKU: E-AB-14011

Size: 200μL

Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.

Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.

Exp date: 12 months

Category ID_II: Primary Antibodies

Category ID_III: Polyclonal Antibodies

Abbreviation: CLDND1

Target Synonym: C3orf4;Chromosome 3 open reading frame 4;Claudin domain containing 1;Claudin domain containing 1 protein;GENX 3745;Membrane protein GENX3745;MGC111162;MGC3316;MGC9861;OTTHUMP00000217407;OTTHUMP00000217408;OTTHUMP00000217423;OTTHUMP00000217424;OTTHUMP00000217562;OTTHUMP00000217563;OTTHUMP00000217584;OTTHUMP00000217585;OTTHUMP00000217586;OTTHUMP00000217587;OTTHUMP00000217609;OTTHUMP00000217610;OTTHUMP00000217611;OTTHUMP00000217622;OTTHUMP00000217623;OTTHUMP00000217625;OTTHUMP00000217627;OTTHUMP00000217628;OTTHUMP00000217638

Research Areas: Cell Biology;Neuroscience

Conjugation: Unconjugated

Host: Rabbit

Species reactivity: Human;Mouse

Application: IHC

Isotype: IgG

Clonality: Polyclonal

Clone NO.:

UNIProt ID: Q9NY35

Accession:

Background: CLDND1 (claudin domain containing 1), also known as C3orf4 or HSPC174, is a 253 amino acid multi-pass membrane protein that is expressed at high levels in adult brain and at lower levels in adult heart. Existing as two alternatively spliced isoforms, CLDND1 is encoded by a gene that maps to human chromosome 3, which houses over 1,100 genes, including a chemokine receptor (CKR) gene cluster and a variety of human cancer-related gene loci. Key tumor suppressing genes on chromosome 3 include those that encode the apoptosis mediator RASSF1, the cell migration regulator HYAL1 and the angiogenesis suppressor SEMA3B. Marfan Syndrome, porphyria, von Hippel-Lindau syndrome, osteogenesis imperfecta and Charcot-Marie-Tooth Disease are a few of the numerous genetic diseases associated with chromosome 3.

Concentration: 0.2 mg/mL

Immunogen: Recombinant protein of human CLDND1

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Purification method: Affinity purification

Dilution: IHC 1:50-1:200

Calculated MW:

ObservedMW: